98 related articles for article (PubMed ID: 8473789)
1. [Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass].
Inui K
Nihon Kyobu Geka Gakkai Zasshi; 1993 Feb; 41(2):238-46. PubMed ID: 8473789
[TBL] [Abstract][Full Text] [Related]
2. Parameters of pulmonary injury after total or partial cardiopulmonary bypass.
Friedman M; Sellke FW; Wang SY; Weintraub RM; Johnson RG
Circulation; 1994 Nov; 90(5 Pt 2):II262-8. PubMed ID: 7955263
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass.
Bando K; Pillai R; Cameron DE; Brawn JD; Winkelstein JA; Hutchins GM; Reitz BA; Baumgartner WA
J Thorac Cardiovasc Surg; 1990 May; 99(5):873-7. PubMed ID: 2329826
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition.
Friedman M; Wang SY; Sellke FW; Franklin A; Weintraub RM; Johnson RG
Ann Thorac Surg; 1995 Mar; 59(3):598-603. PubMed ID: 7887696
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary bypass primes polymorphonuclear leukocytes.
Schwartz JD; Shamamian P; Schwartz DS; Grossi EA; Jacobs CE; Steiner F; Minneci PC; Baumann FG; Colvin SB; Galloway AC
J Surg Res; 1998 Mar; 75(2):177-82. PubMed ID: 9655092
[TBL] [Abstract][Full Text] [Related]
7. Prevention of ischemia/reperfusion-induced pulmonary dysfunction after cardiopulmonary bypass with terminal leukocyte-depleted lung reperfusion.
Kagawa H; Morita K; Nagahori R; Shinohara G; Kinouchi K; Hashimoto K
J Thorac Cardiovasc Surg; 2010 Jan; 139(1):174-80. PubMed ID: 19919867
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of continuous pulmonary perfusion during total cardiopulmonary bypass to prevent lung reperfusion injury].
Suzuki T; Fukuda T; Inoue Y; Aki A; Cho Y
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):31-6. PubMed ID: 9028120
[TBL] [Abstract][Full Text] [Related]
9. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
[TBL] [Abstract][Full Text] [Related]
10. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study.
Alexiou C; Tang AA; Sheppard SV; Smith DC; Gibbs R; Livesey SA; Monro JL; Haw MP
Eur J Cardiothorac Surg; 2004 Aug; 26(2):294-300. PubMed ID: 15296886
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
Marzi I; Bauer M; Reisdorf E; Walcher F
Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
[TBL] [Abstract][Full Text] [Related]
12. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
Banz Y; Rieben R; Zobrist C; Meier P; Shaw S; Lanz J; Carrel T; Berdat P
Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.
Mojarad M; Hamasaki Y; Said SI
Bull Eur Physiopathol Respir; 1983; 19(3):253-6. PubMed ID: 6882949
[TBL] [Abstract][Full Text] [Related]
14. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
15. Effects of the platelet-activating factor receptor antagonist BN 52021 on hematologic variables and blood loss during and after cardiopulmonary bypass.
Nathan N; Mercury P; Denizot Y; Cornu E; Laskar M; Arnoux B; Feiss P
Anesth Analg; 1994 Aug; 79(2):205-11. PubMed ID: 7639352
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor is involved in the regulation of pathological leukocyte adhesion after liver transplantation.
Walcher F; Marzi I; Fischer R; Bauer M; Larsen R
J Surg Res; 1996 Feb; 61(1):244-9. PubMed ID: 8769973
[TBL] [Abstract][Full Text] [Related]
17. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass.
Chen YF; Tsai WC; Lin CC; Tsai LY; Lee CS; Huang CH; Pan PC; Chen ML
Ann Thorac Surg; 2004 Aug; 78(2):634-42; discussion 642-3. PubMed ID: 15276536
[TBL] [Abstract][Full Text] [Related]
18. [The dynamics of blood composition changes in leukocyte filtration during cardiopulmonary bypass. Preliminary results].
Mihaljevic T; Tönz M; Pasic M; Engel M; von Segesser LK; Turina M
Helv Chir Acta; 1993 Dec; 60(3):403-6. PubMed ID: 8119822
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor mediates interleukin-2-induced lung injury in the rat.
Rabinovici R; Sofronski MD; Renz JF; Hillegas LM; Esser KM; Vernick J; Feuerstein G
J Clin Invest; 1992 May; 89(5):1669-73. PubMed ID: 1314853
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
